Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: A consensus-based SIE, SIES, GITMO position paper-Reference-Cited by-同舟云学术

Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: A consensus-based SIE, SIES, GITMO position paper

Published:2014-02 Issue:2 Volume:38 Page:155-160
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Barosi Giovanni,Vannucchi Alessandro M.,De Stefano Valerio,Pane Fabrizio,Passamonti Francesco,Rambaldi Alessandro,Saglio Giuseppe,Barbui Tiziano,Tura Sante

Funder

Associazione Italiana per la Ricerca sul Cancro (AIRC Milano)

Special Program Molecular Clinical Oncology 5×1000

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference52 articles.

1. Incidence, survival and prevalence of myeloid malignancies in Europe;Visser;Eur J Cancer,2012

2. Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression;Klampfl;Blood,2011

3. WHO classification of tumours of haematopoietic and lymphoid tissues,2008

4. Revised response criteria for polycythemia vera and essential thrombocythemia: a ELN and IWG-MRT consensus project;Barosi;Blood,2013

5. Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European LeukemiaNet (ELN) Consensus Report;Tefferi;Blood,2013

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective;Leukemia Research;2024-01

2. Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort;Annals of Hematology;2023-04-20

3. How I manage myeloproliferative neoplasm‐unclassifiable: Practical approaches for 2022 and beyond;British Journal of Haematology;2022-02-22

4. New Markers of Disease Progression in Myelofibrosis;Cancers;2021-10-23

5. The new WHO classification for essential thrombocythemia calls for revision of available evidences;Blood Cancer Journal;2020-02